PATENT CLAIM ANALYSIS

Application Number: 15747646
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "085000"]

Abstract:
Provided are compositions which include N-methyl-d-aspartate receptor (NMDA-R) antagonists. Moreover, provided are methods for reducing the permeability of the blood-brain-barrier, in a patient, by administering to the patient, a composition which includes N-methyl-d-aspartate receptor (NMDA-R) antagonists.

Claim (Index 8):
A method for preventing an increase in the permeability of the blood-brain-barrier, in a subject at risk of a brain injury, comprising administering to said subject, a composition comprising N-methyl-d-aspartate receptor (NMDA-R) antagonist, thereby preventing an increase in the permeability of the blood-brain-barrier, in a subject at risk of a brain injury.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 86.0
- Lexical Diversity: 1.53333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12922551', '10849540', '13830615', '15649460', '12160035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7553447380410262
- 35 USC 102 Novelty (BERT): 0.4994131485540032
- Combined Prediction Score: 0.7297515790923239
- Mean Citation Score: 243.15353800000003
- Max Citation Score: 252.18817
- Similarity Product: 184.9881407136178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test